$MMSI
MERIT MEDICAL SYSTEMS INC

2023 Q3 Form 10-Q Financial Statement

#000085698223000049 Filed on July 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $315.2M $320.1M
YoY Change 9.77% 8.5%
Cost Of Revenue $173.0M $167.3M
YoY Change 9.1% 4.61%
Gross Profit $142.2M $152.8M
YoY Change 10.6% 13.12%
Gross Profit Margin 45.11% 47.74%
Selling, General & Admin $86.85M $100.9M
YoY Change -3.26% 18.06%
% of Gross Profit 61.08% 66.06%
Research & Development $19.65M $21.68M
YoY Change 2.21% 17.4%
% of Gross Profit 13.82% 14.19%
Depreciation & Amortization $24.10M $21.78M
YoY Change 18.08% 6.57%
% of Gross Profit 16.95% 14.25%
Operating Expenses $107.1M $123.7M
YoY Change -2.6% 10.63%
Operating Profit $35.14M $29.08M
YoY Change 88.33% 25.05%
Interest Expense $4.841M -$3.461M
YoY Change 164.39% -356.75%
% of Operating Profit 13.78% -11.9%
Other Income/Expense, Net -$4.915M -$451.0K
YoY Change 365.88% -82.35%
Pretax Income $30.22M $24.90M
YoY Change 71.7% 20.28%
Income Tax $4.388M $4.655M
% Of Pretax Income 14.52% 18.69%
Net Earnings $25.83M $20.25M
YoY Change 69.16% 32.34%
Net Earnings / Revenue 8.2% 6.33%
Basic Earnings Per Share $0.45 $0.35
Diluted Earnings Per Share $0.44 $0.35
COMMON SHARES
Basic Shares Outstanding 57.64M 57.49M
Diluted Shares Outstanding 58.38M 58.47M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $58.70M $72.08M
YoY Change 14.02% 14.41%
Cash & Equivalents $58.67M $72.08M
Short-Term Investments
Other Short-Term Assets $31.90M $28.89M
YoY Change 3.23% 8.69%
Inventory $303.9M $305.9M
Prepaid Expenses
Receivables $167.8M $171.0M
Other Receivables $23.00M $17.00M
Total Short-Term Assets $585.3M $594.9M
YoY Change 17.1% 20.76%
LONG-TERM ASSETS
Property, Plant & Equipment $383.3M $446.8M
YoY Change 1.91% 20.28%
Goodwill $381.1M $381.8M
YoY Change 6.42% 6.14%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $48.55M $58.98M
YoY Change 9.37% 36.21%
Total Long-Term Assets $1.223B $1.243B
YoY Change 7.97% 9.11%
TOTAL ASSETS
Total Short-Term Assets $585.3M $594.9M
Total Long-Term Assets $1.223B $1.243B
Total Assets $1.809B $1.838B
YoY Change 10.77% 12.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.90M $61.76M
YoY Change -22.63% 3.9%
Accrued Expenses $119.3M $122.2M
YoY Change -4.19% 9.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.750M $3.750M
YoY Change -66.67% -63.64%
Total Short-Term Liabilities $187.1M $190.0M
YoY Change -12.16% -2.86%
LONG-TERM LIABILITIES
Long-Term Debt $282.4M $335.2M
YoY Change 37.47% 42.23%
Other Long-Term Liabilities $13.81M $90.16M
YoY Change -16.29% 415.91%
Total Long-Term Liabilities $296.2M $425.4M
YoY Change 33.47% 68.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $187.1M $190.0M
Total Long-Term Liabilities $296.2M $425.4M
Total Liabilities $578.6M $633.9M
YoY Change 6.38% 13.55%
SHAREHOLDERS EQUITY
Retained Earnings $547.6M $521.7M
YoY Change 22.39% 20.74%
Common Stock $695.2M $691.5M
YoY Change 5.62% 6.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.230B $1.204B
YoY Change
Total Liabilities & Shareholders Equity $1.809B $1.838B
YoY Change 10.77% 12.63%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $25.83M $20.25M
YoY Change 69.16% 32.34%
Depreciation, Depletion And Amortization $24.10M $21.78M
YoY Change 18.08% 6.57%
Cash From Operating Activities $51.10M $17.29M
YoY Change 43.99% -55.43%
INVESTING ACTIVITIES
Capital Expenditures $8.600M $5.771M
YoY Change -154.51% -179.74%
Acquisitions
YoY Change
Other Investing Activities -$700.0K -$137.1M
YoY Change -29.51% 2113.82%
Cash From Investing Activities -$9.200M -$142.9M
YoY Change -45.14% 963.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -54.50M 141.5M
YoY Change 101.35% -1171.69%
NET CHANGE
Cash From Operating Activities 51.10M 17.29M
Cash From Investing Activities -9.200M -142.9M
Cash From Financing Activities -54.50M 141.5M
Net Change In Cash -12.60M 15.90M
YoY Change 50.95% 30.85%
FREE CASH FLOW
Cash From Operating Activities $51.10M $17.29M
Capital Expenditures $8.600M $5.771M
Free Cash Flow $42.50M $11.52M
YoY Change -17.1% -74.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
dei Entity Central Index Key
EntityCentralIndexKey
0000856982
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
MERIT MEDICAL SYSTEMS INC
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57634000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57306000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-18592
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0447695
dei Entity Address Address Line1
EntityAddressAddressLine1
1600 West Merit Parkway
dei Entity Address City Or Town
EntityAddressCityOrTown
South Jordan
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84095
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
253-1600
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
MMSI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57635381
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72084000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58408000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8652000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8423000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170990000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164677000
CY2023Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
12634000
CY2022Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
12992000
CY2023Q2 us-gaap Inventory Net
InventoryNet
305943000
CY2022Q4 us-gaap Inventory Net
InventoryNet
265991000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24971000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22324000
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
3920000
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3913000
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4365000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
779000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
594907000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
529084000
CY2023Q2 us-gaap Land
Land
26017000
CY2022Q4 us-gaap Land
Land
25940000
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
189900000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
189148000
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
306925000
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
299089000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1154000
CY2023Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
66046000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
61128000
CY2023Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
52604000
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
49673000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
62374000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
61269000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
703866000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
686247000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
319504000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
303271000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
384362000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
382976000
CY2023Q2 us-gaap Goodwill
Goodwill
381767000
CY2022Q4 us-gaap Goodwill
Goodwill
359821000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6492000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6599000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62436000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
65262000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
52492000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44352000
CY2023Q2 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
858299000
CY2022Q4 mmsi Intangible Assets Net Goodwill And Other Assets Noncurrent
IntangibleAssetsNetGoodwillAndOtherAssetsNoncurrent
751906000
CY2023Q2 us-gaap Assets
Assets
1837568000
CY2022Q4 us-gaap Assets
Assets
1663966000
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
61761000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
68504000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
110662000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
123189000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11250000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11531000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11005000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2299000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6697000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
190003000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
220645000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
335232000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
186759000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18477000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18462000
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
347000
CY2023Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1912000
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1912000
CY2023Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
16418000
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
15264000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1657000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1708000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
56599000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59736000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13223000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14736000
CY2023Q2 us-gaap Liabilities
Liabilities
633868000
CY2022Q4 us-gaap Liabilities
Liabilities
519569000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57634000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57306000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
691523000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
675174000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
521721000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
480773000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9544000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11550000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1203700000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1144397000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1837568000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1663966000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
320056000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294976000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
617621000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
570391000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167274000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
159909000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
326477000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
314417000
CY2023Q2 us-gaap Gross Profit
GrossProfit
152782000
CY2022Q2 us-gaap Gross Profit
GrossProfit
135067000
us-gaap Gross Profit
GrossProfit
291144000
us-gaap Gross Profit
GrossProfit
255974000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100927000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
85487000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
191071000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169502000
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
20129000
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
18466000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
41443000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
35853000
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
270000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
270000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1672000
CY2023Q2 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-1094000
CY2022Q2 mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-1187000
mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-1615000
mmsi Business Combination Contingent Consideration Arrangements Contingent Consideration Benefit
BusinessCombinationContingentConsiderationArrangementsContingentConsiderationBenefit
-3787000
CY2023Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
1550000
CY2022Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6671000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
1550000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6671000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
123970000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
111811000
us-gaap Operating Expenses
OperatingExpenses
235949000
us-gaap Operating Expenses
OperatingExpenses
217485000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28812000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
23256000
us-gaap Operating Income Loss
OperatingIncomeLoss
55195000
us-gaap Operating Income Loss
OperatingIncomeLoss
38489000
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
221000
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
96000
us-gaap Investment Income Net
InvestmentIncomeNet
352000
us-gaap Investment Income Net
InvestmentIncomeNet
201000
CY2023Q2 us-gaap Interest Expense
InterestExpense
3682000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1348000
us-gaap Interest Expense
InterestExpense
5693000
us-gaap Interest Expense
InterestExpense
2350000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-451000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1303000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
546000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1468000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3912000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2555000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4795000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3617000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24900000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20701000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50400000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34872000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4655000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5403000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9452000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9029000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
20245000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15298000
us-gaap Net Income Loss
NetIncomeLoss
40948000
us-gaap Net Income Loss
NetIncomeLoss
25843000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57537000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56691000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57445000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56642000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58473000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57600000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58329000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57565000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
20245000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15298000
us-gaap Net Income Loss
NetIncomeLoss
40948000
us-gaap Net Income Loss
NetIncomeLoss
25843000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
3422000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
6425000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
1731000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
9332000
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
821000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
1572000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
415000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
2284000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-1201000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-8979000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
724000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-9772000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
15000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-60000
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
34000
us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
4000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1385000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4066000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2006000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2728000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
21630000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11232000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
42954000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
23115000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1144397000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
20703000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
621000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3498000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3726000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
302000
CY2023Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
1592000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1171655000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
20245000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1385000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4980000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5154000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
281000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1203700000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1039799000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
10545000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1338000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4212000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1320000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
320000
CY2022Q1 mmsi Stock Surrendered During Period Value Payroll Tax Liabilities Stock Options Exercised
StockSurrenderedDuringPeriodValuePayrollTaxLiabilitiesStockOptionsExercised
1015000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1056519000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15298000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4066000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3952000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1303000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
301000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1073307000
us-gaap Net Income Loss
NetIncomeLoss
40948000
us-gaap Net Income Loss
NetIncomeLoss
25843000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42316000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40902000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-1254000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4677000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-112000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
328000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1733000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
1550000
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
6671000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5935000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5121000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1615000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1999000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
52000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
54000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
462000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
302000
us-gaap Share Based Compensation
ShareBasedCompensation
9549000
us-gaap Share Based Compensation
ShareBasedCompensation
9093000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5980000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9472000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-287000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-6457000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35502000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14766000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-78000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2155000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3577000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1558000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1768000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-7253000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3713000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10295000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20966000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4896000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1114000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-2549000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5711000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5609000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2244000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
287000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-9117000
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
24951000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31831000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
50794000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18556000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16763000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1047000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
912000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
201000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
59000
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
-971000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
138349000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4712000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-157751000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23299000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9463000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3244000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
460283000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
127688000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
318471000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
124563000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5240000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3434000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
32798000
mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
1592000
mmsi Payments Related To Tax Withholding For Exchange Of Common Stock
PaymentsRelatedToTaxWithholdingForExchangeOfCommonStock
1015000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
141009000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27444000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1497000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2564000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13592000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2513000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60558000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67750000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74150000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65237000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72084000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63003000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2066000
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2234000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74150000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65237000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
597000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
302000
us-gaap Interest Paid Net
InterestPaidNet
3681000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24200000
us-gaap Interest Paid Net
InterestPaidNet
2317000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17787000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7863000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4291000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3555000
mmsi Acquisition Of Developed Technology In Accrued Expenses
AcquisitionOfDevelopedTechnologyInAccruedExpenses
3635000
mmsi Acquisition Of Developed Technology In Accrued Expenses
AcquisitionOfDevelopedTechnologyInAccruedExpenses
3526000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3399000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4746000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
320056000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294976000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
617621000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
570391000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
155934000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
147051000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
33780000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
29534000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
116229000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
89406000
CY2023Q2 us-gaap Inventory Net
InventoryNet
305943000
CY2022Q4 us-gaap Inventory Net
InventoryNet
265991000
CY2022Q4 us-gaap Goodwill
Goodwill
359821000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
410000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
21536000
CY2023Q2 us-gaap Goodwill
Goodwill
381767000
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
8300000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25700000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
32085000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
59732000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
57701000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
46963000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
43768000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4700000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5400000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.187
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000000.0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.188
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.259
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1018000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
179000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
338982000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
198009000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11250000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
335232000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
186759000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1875000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3750000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
5625000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7500000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9375000
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
311875000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
340000000
CY2023Q2 us-gaap Interest Expense
InterestExpense
3682000
CY2022Q2 us-gaap Interest Expense
InterestExpense
1348000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
320056000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294976000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167274000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
159909000
us-gaap Interest Expense
InterestExpense
5693000
us-gaap Interest Expense
InterestExpense
2350000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
617621000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
570391000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
326477000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
314417000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
20245000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15298000
us-gaap Net Income Loss
NetIncomeLoss
40948000
us-gaap Net Income Loss
NetIncomeLoss
25843000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57537000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56691000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57445000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56642000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57537000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56691000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57445000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56642000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
936000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
909000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
884000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
923000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58473000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57600000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58329000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57565000
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1114000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1641000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1014000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1597000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5580000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4451000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9549000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9093000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
320056000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294976000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
617621000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
570391000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
28812000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
23256000
us-gaap Operating Income Loss
OperatingIncomeLoss
55195000
us-gaap Operating Income Loss
OperatingIncomeLoss
38489000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3912000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2555000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4795000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3617000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4655000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5403000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9452000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9029000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
20245000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
15298000
us-gaap Net Income Loss
NetIncomeLoss
40948000
us-gaap Net Income Loss
NetIncomeLoss
25843000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
3400000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
32800000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
12700000
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1800000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
290000
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
199000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
281000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
199000
CY2023Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
6000
CY2022Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-7000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
15000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-7000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
296000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
192000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
296000
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
192000
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000856982-23-000049-index-headers.html Edgar Link pending
0000856982-23-000049-index.html Edgar Link pending
0000856982-23-000049.txt Edgar Link pending
0000856982-23-000049-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmsi-20230630.xsd Edgar Link pending
mmsi-20230630x10q.htm Edgar Link pending
mmsi-20230630x10q001.jpg Edgar Link pending
mmsi-20230630xex10d1.htm Edgar Link pending
mmsi-20230630xex10d2.htm Edgar Link pending
mmsi-20230630xex10d3.htm Edgar Link pending
mmsi-20230630xex31d1.htm Edgar Link pending
mmsi-20230630xex31d2.htm Edgar Link pending
mmsi-20230630xex32d1.htm Edgar Link pending
mmsi-20230630xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mmsi-20230630_cal.xml Edgar Link unprocessable
mmsi-20230630_def.xml Edgar Link unprocessable
mmsi-20230630_lab.xml Edgar Link unprocessable
mmsi-20230630_pre.xml Edgar Link unprocessable
mmsi-20230630x10q_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending